Differences of immunohistochemical profiling of MOC-31, caveolin-1, connexin-43, Ki-67 in ameloblastic fibroma, ameloblastic fibrodentinoma, ameloblastic fibro-odontoma, and odontomas

doi:10.5493/wjem.v16.i1.115508

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 1

This Article

(39)

(0)

(815)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Experimental Medicine

ISSN

2220-315x

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Exp Med. Mar 20, 2026; 16(1): 115508
Published online Mar 20, 2026. doi: 10.5493/wjem.v16.i1.115508

Table 2 Mixed-effects logistic regression model

Variable	LRT	gL	P value	OR
OT	15	3	0.0020^b
Biomarker	17	3	< 0.0010^c
Sex	0	1	0.9720
Age	6	1	0.0110^a	0.93

^aP < 0.05.

^bP < 0.01.

^cP < 0.001.

Model used to compare the behavior of biomarkers according to the variable: Type of neoplasia (ameloblastic fibrodentinoma/ameloblastic fibro-odontoma, ameloblastic fibroma, odontoma, pericoronary caps); sex; and age. Only the factors affecting the expression of biomarkers are shown. OT: Odontogenic tumor; LRT: Likelihood ratio test statistic; OR: Odds ratio.

Full Size Table

Citation: Umpiérrez NG, Sicco E, Silveira F, Beovide AV, Bologna-Molina R. Differences of immunohistochemical profiling of MOC-31, caveolin-1, connexin-43, Ki-67 in ameloblastic fibroma, ameloblastic fibrodentinoma, ameloblastic fibro-odontoma, and odontomas. World J Exp Med 2026; 16(1): 115508
URL: https://www.wjgnet.com/2220-315x/full/v16/i1/115508.htm
DOI: https://dx.doi.org/10.5493/wjem.v16.i1.115508

Umpiérrez NG, Sicco E, Silveira F, Beovide AV, Bologna-Molina R. Differences of immunohistochemical profiling of MOC-31, caveolin-1, connexin-43, Ki-67 in ameloblastic fibroma, ameloblastic fibrodentinoma, ameloblastic fibro-odontoma, and odontomas. World J Exp Med 2026; 16(1): 115508 [PMID: 41883438 DOI: 10.5493/wjem.v16.i1.115508]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.